TipRanks
Go Ultimate55% OFF

Syndax Pharmaceuticals (SNDX) Revenue

1,059 Followers

Syndax Pharmaceuticals Revenue

Syndax Pharmaceuticals had a revenue of 83.30M in the quarter ending Sep 30, 2026, with 14.44%. This bring the company's revenue in the last twelve months to 289.43M, Increased 14.85%. In the fiscal year ending Dec 31, 2025, Syndax Pharmaceuticals had annual revenue of 172.35M with 627.84% growth.

Revenue (ttm)
289.43M
Revenue Growth
159.68%
P/S Ratio
7.46
Revenue/Employee
$578,362
Employees
298
Market Cap
$1.29B

Revenue Chart

Syndax Pharmaceuticals Revenue - Annual

050M100M150M200M2.11M1.52M1.52M1.52M139.71M23.68M172.35M201720182019202020212022202320242025
Revenue History
Download to Excel
SNDX revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025172.35M148.67M627.84%
Dec 31, 202423.68M23.68M―
Dec 31, 20230.000.00―
Dec 31, 20220.00-139.71M-100.00%
Dec 31, 2021139.71M138.19M9109.56%
Dec 31, 20201.52M0.000.00%
Dec 31, 20191.52M0.000.00%
Dec 31, 20181.52M-591.00K-28.04%
Dec 31, 20172.11M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
SNDX289.43M
NKTR54.59M
XNCR200.49M
KURA77.22M
ORIC0.00
IMCR403.72M